Decrease of antiparkinsonian drugs before start of an antipsychotic in patients on levodopa treatment?

Author： van de Vijver David A.M.C.   Roos Raymund A.C.   Jansen Paul A.F.   Porsius Arijan J.   de Boer Anthonius  

Publisher： Springer Publishing Company

ISSN： 0928-1231

Source： Pharmacy World and Science, Vol.26, Iss.5, 2004-10, pp. : 277-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of Antipsychotic Drugs in Schizophrenia Treatment

By Tybura Piotr   Trzesniowska-Drukala Beata   Samochowiec Jerzy  

Current Psychopharmacology, Vol. 1, Iss. 1, 2012-02 ,pp. : 47-60

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of Antipsychotic Drugs in Schizophrenia Treatment

By  

Current Psychopharmacology, Vol. 1, Iss. 1, 2012-02 ,pp. : 47-60

Bentham Science Publishers

Access to resources Recommend Favorite

Manage levodopa-induced motor complications in patients with Parkinson's disease with careful selection of other antiparkinsonian agents

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 1, 2008-01 ,pp. : 17-21

Adis International

Access to resources Recommend Favorite

Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients

By Arbouw Maurits   Movig Kris   Neef Cees   Guchelaar Henk-Jan   Egberts Toine  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 2, 2007-02 ,pp. : 181-187

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of the Metabolic Disturbances Caused by Antipsychotic Drugs: Focus on Potential Drug Interactions

By Baptista T.   N.M.K. Ng Ying Kin   Beaulieu S.  

Clinical Pharmacokinetics, Vol. 43, Iss. 1, 2004-01 ,pp. : 1-15

Adis International

Access to resources Recommend Favorite